Insider and congress filings
Medtronic plc (MDT)
About Medtronic plc
from the company's filings and listing- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical - Devices
- Chief executive
- Geoffrey Straub Martha
- Employees
- 95,000
- Listed since
- -
- Market value
- $117.6B
- Price to earnings
- 22.5
- Earnings per share
- $4.09
- Dividend yield
- 3.10%
Earnings
6 reported quarters · next on Nov 17, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q1 FY2027reported Sep 1, 2026 | $1.45 | $1.39 | $9.8B | $9.5B | EPS beatRevenue beat |
| Jun 3, 2026 | $1.55 | $1.54 | $9.8B | $9.6B | EPS in lineRevenue beat |
| Q3 FY2026reported Feb 17, 2026 | $1.36 | $1.34 | $9.0B | $8.9B | EPS in lineRevenue in line |
| Q2 FY2026reported Nov 18, 2025 | $1.36 | $1.31 | $9.0B | $8.9B | EPS beatRevenue in line |
| Q1 FY2026reported Aug 19, 2025 | $1.26 | $1.23 | $8.6B | $8.4B | EPS beatRevenue beat |
| May 21, 2025 | $1.62 | $1.58 | $8.9B | $8.8B | EPS beatRevenue in line |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2026 · proxy filed Aug 17, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Geoff MarthaChairman and Chief Executive Officer | $1.4M | $13.7M | $7.9M | $22.9M |
| Thierry PiétonEVP, Chief Financial Officer | $850K | $3.2M | $4.6M | $8.6M |
| Mike MarinaroEVP & President Medical Surgical Portfolio & Americas | $820K | $3.6M | $2.4M | $6.8M |
| Michelle QuinnEVP, General Counsel and Secretary | $600K | $3.5M | $2.6M | $6.7M |
The summary compensation table from the 2026 proxy statement, current executives only. 1 executive who has since left the company is named in that filing and not shown here. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| Blackrock, Inc. | $8.9B | 114,020,787 | +0.7% | 8.91% |
| Vanguard Capital Management LLC | $6.6B | 83,816,735 | +0.6% | 6.55% |
| State Street Corp | $5.0B | 63,399,315 | +2.7% | 4.95% |
| Vanguard Portfolio Management LLC | $2.7B | 34,059,967 | +1.8% | 2.66% |
| Massachusetts Financial Services Co | $2.6B | 19,872,600 | -7.3% | 1.55% |
| Geode Capital Management, LLC | $2.4B | 30,192,015 | +5.1% | 2.36% |
| Jpmorgan Chase & Co | $2.2B | 27,784,471 | -45.5% | 2.17% |
| Bank Of America Corp | $1.7B | 21,322,401 | -18.0% | 1.67% |
| Morgan Stanley | $1.5B | 19,444,871 | -6.1% | 1.52% |
| Deutsche Bank Ag\ | $1.4B | 18,449,877 | -2.9% | 1.44% |
| Invesco Ltd. | $1.4B | 17,885,150 | +6.5% | 1.40% |
| Franklin Resources Inc | $1.4B | 17,550,983 | +23.8% | 1.37% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Open-market insider trades
2 filings of 351 on record| Insider | Action | Shares | Price | Value | Trade date | Delay |
|---|---|---|---|---|---|---|
| Matthew R. WalterSVP, Chief HR Officer | Sold | 3,102 | $83.15 | $258K | Jul 8, 2026 | 1d |
| Harry Skip KiilEVP & President Cardiovascular | Sold · 2 lines | 4,189 | $80.44 | $337K | Jun 8, 2026 | 1d |
One row is one filing. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count.
Congress trades in MDT
20 disclosures of 177 on record · median 25d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Kevin HernJoint | Stock | Sale | $15,001 - $50,000 | -1.1%S&P -0.1% · vs S&P 500 -0.9% | Aug 24, 2026 | Sep 1, 2026 | 8d |
| Richard McCormick | Stock | Sale | $1,001 - $15,000 | +7.2%S&P +2.8% · vs S&P 500 +4.4% | Jul 30, 2026 | Aug 14, 2026 | 15d |
| Julie JohnsonJointFiled late | Stock | Sale | $1,001 - $15,000 | +10.5%S&P +35.9% · vs S&P 500 -25.4% | May 7, 2025 | Aug 5, 2026 | 455d |
| Alan ArmstrongSelfFiled late | Stock | Purchase | $1,001 - $15,000 | +5.5%S&P +20.2% · vs S&P 500 -14.8% | Mar 27, 2026 | Jul 21, 2026 | 116d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +20.7%S&P +3.2% · vs S&P 500 +17.5% | May 15, 2026 | Jun 9, 2026 | 25d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +20.9%S&P +1.6% · vs S&P 500 +19.4% | May 27, 2026 | Jun 9, 2026 | 13d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | +20.7%S&P +3.2% · vs S&P 500 +17.5% | May 15, 2026 | Jun 8, 2026 | 24d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +7.8%S&P +21.2% · vs S&P 500 -13.4% | Mar 30, 2026 | Apr 7, 2026 | 8d |
| Ro Khanna | Stock | Sale | $15,001 - $50,000 | +2.2%S&P +12.6% · vs S&P 500 -10.3% | Mar 10, 2026 | Apr 7, 2026 | 28d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +5.4%S&P +16.0% · vs S&P 500 -10.5% | Mar 23, 2026 | Apr 7, 2026 | 15d |
| Kevin HernJoint | Stock | Sale | $15,001 - $50,000 | +6.7%S&P +17.2% · vs S&P 500 -10.6% | Mar 20, 2026 | Apr 3, 2026 | 14d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -9.3%S&P +10.6% · vs S&P 500 -19.9% | Jan 22, 2026 | Feb 6, 2026 | 15d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -8.9%S&P +10.6% · vs S&P 500 -19.5% | Jan 23, 2026 | Feb 6, 2026 | 14d |
| Julie JohnsonJoint | Stock | Sale | $1,001 - $15,000 | -6.7%S&P +12.7% · vs S&P 500 -19.4% | Dec 18, 2025 | Jan 15, 2026 | 28d |
| Julie JohnsonJoint | Stock | Sale | $1,001 - $15,000 | -4.4%S&P +13.4% · vs S&P 500 -17.8% | Nov 13, 2025 | Dec 11, 2025 | 28d |
| Richard McCormick | Stock | Purchase | $1,001 - $15,000 | +2.4%S&P +12.7% · vs S&P 500 -10.3% | Nov 5, 2025 | Dec 9, 2025 | 34d |
| Richard McCormickFiled late | Stock | Purchase | $1,001 - $15,000 | +18.0%S&P +96.2% · vs S&P 500 -78.2% | Mar 15, 2023 | Sep 17, 2025 | 917d |
| Julie JohnsonJoint | Stock | Sale | $1,001 - $15,000 | -0.1%S&P +18.2% · vs S&P 500 -18.3% | Aug 14, 2025 | Sep 11, 2025 | 28d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +2.5%S&P +20.8% · vs S&P 500 -18.3% | Aug 4, 2025 | Sep 9, 2025 | 36d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +6.8%S&P +23.6% · vs S&P 500 -16.8% | Jun 27, 2025 | Jul 9, 2025 | 12d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Members of Congress reporting a position
14 members · estimate, as of Sep 10, 202614 members report a position (estimated). The largest estimated position is in the $15,001 - $50,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| Gary C. Peters | Democrat · Senate | $15,001 - $50,000 | 1.0% |
| Debbie Dingell | Democrat · House | $15,001 - $50,000 | 0.4% |
| Robert Bresnahan | Republican · House | $15,001 - $50,000 | 0.2% |
| Gilbert Ray Cisneros, Jr. | Democrat · House | $15,001 - $50,000 | 0.1% |
| Daniel Meuser | Republican · House | $15,001 - $50,000 | 0.7% |
| Harriet M. Hageman | Republican · House | $15,001 - $50,000 | 0.5% |
| George Whitesides | Democrat · House | $1,001 - $15,000 | 0.1% |
| Ron Wyden | Democrat · Senate | $1,001 - $15,000 | 0.1% |
| Shelley Moore Capito | Republican · Senate | $1,001 - $15,000 | 0.4% |
| Cliff Bentz | Republican · House | $1,001 - $15,000 | 0.5% |
| James Comer | Republican · House | $1,001 - $15,000 | 1.7% |
| Robert B. Aderholt | Republican · House | $1,001 - $15,000 | 1.0% |
| Robert Onder | Republican · House | $1,001 - $15,000 | 0.2% |
| Richard McCormick | Republican · House | $1,001 - $15,000 | 2.3% |
Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Awards, option exercises and gifts (20)
| Insider | Event | Shares | Date |
|---|---|---|---|
| Michael MarinaroEVP, Pres Medsurg and Americas | Tax withholding | 1,084 | Aug 20, 2026 |
| Harry Skip KiilEVP & President Cardiovascular | Stock award | 97,860 | Aug 3, 2026 |
| Kweli ThompsonEVP & President, Neuroscience | Stock award | 73,396 | Aug 3, 2026 |
| Kweli ThompsonEVP & President, Neuroscience | Tax withholding | 1,739 | Jul 31, 2026 |
| Geoffrey MarthaChairman and CEO | Stock award | 713,516 | Aug 3, 2026 |
| Geoffrey MarthaChairman and CEO | Tax withholding | 15,810 | Jul 31, 2026 |
| Michael MarinaroEVP, Pres Medsurg and Americas | Stock award | 162,355 | Aug 3, 2026 |
| Thierry PietonEVP & Chief Financial Officer | Stock award | 122,324 | Aug 3, 2026 |
| Michelle QuinnEVP, GC and Secretary | Stock award | 67,279 | Aug 3, 2026 |
| Denise L. BlomquistChief Accounting Officer | Tax withholding | 212 | Jul 31, 2026 |
| Denise L. BlomquistChief Accounting Officer | Stock award | 3,703 | Aug 3, 2026 |
| Matthew R. WalterSVP, Chief HR Officer | Tax withholding | 1,675 | Jul 31, 2026 |
| Matthew R. WalterSVP, Chief HR Officer | Stock award | 61,163 | Aug 3, 2026 |
| Harry Skip KiilEVP & President Cardiovascular | Tax withholding | 3,074 | Jul 31, 2026 |
| Michael MarinaroEVP, Pres Medsurg and Americas | Tax withholding | 3,356 | Jul 31, 2026 |
| Michelle QuinnEVP, GC and Secretary | Tax withholding | 2,069 | Jul 28, 2026 |
| Kweli ThompsonEVP & President, Neuroscience | Form 4 | 1,540 | Jul 29, 2025 |
| Kweli ThompsonEVP & President, Neuroscience | Form 4 | 12,432 | Jun 18, 2026 |
| Kweli ThompsonEVP & President, Neuroscience | Form 4 | 1,704 | Aug 1, 2017 |
| Kweli ThompsonEVP & President, Neuroscience | Form 4 | 1,608 | Jan 30, 2018 |
Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.
Questions
Are insiders buying or selling MDT?
Across the 2 most recent open-market filings shown here, 0 were purchases and 2 were sales.
Which members of Congress have traded MDT?
Kevin Hern, Richard McCormick, Julie Johnson, Alan Armstrong, Ro Khanna, Gilbert Ray Cisneros, Jr. disclosed MDT transactions in the filings shown here.
Which members of Congress hold MDT?
14 members of Congress report a position in MDT in the estimate we hold as of Sep 10, 2026. The three largest estimated positions belong to Gary C. Peters, Debbie Dingell and Robert Bresnahan. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
Is MDT in the S&P 500 or the Nasdaq 100?
Medtronic plc is a current member of the S&P 500, per the membership list we hold as of Sep 10, 2026. Current members of either index get a page here whatever their filing history.
How quickly are MDT trades disclosed?
Insider filings on this page reached the public a median of 1 days after the transaction, against the two business days Form 4 allows. Congressional disclosures took a median of 25 days, against the 45 the STOCK Act allows.
How to read a Form 4
A DECISION THE INSIDER MADE
COMPENSATION PLUMBING
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.